For tumor type, several statistically significant differences were observed, notably patients with ovarian cancer had an AAG of around 249.3 mg/dl compared to the mean total value of 153.3 mg/dl (i.e., 63% higher), as well as patients with pancreatic, gastric, or hepatic cancer who had ALK values of 195.2, 169.7, and 164.5 U/L, respectively, compared to the mean total value of 111.3 U/L (i.e., 48 to 75% higher). This evidence concerns the gene ALK and ovarian carcinoma.